Topics
High-grade gliomas | Treatment | Targeted therapy | Vemurafenib
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Vemurafenib
Nelson
MV, Kim A, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD,
Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju
A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV,
Janeway KA, Seibel NL, Parsons DW.
Phase
II study of vemurafenib in children and young adults with tumors
harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial
(APEC1621) Arm G.
Oncologist.
2024 Jun 14:oyae119. doi:
10.1093/oncolo/oyae119. PMID:
38873934. Interventional study. ˍ